Oncology Institute Inc (TOI)

Currency in USD
3.715
+0.095(+2.62%)
Real-time Data·
TOI Scorecard
Full Analysis
Analysts do not anticipate the company will be profitable this year
Earnings results expected in 14 days
Fair Value
Day's Range
3.6103.815
52 wk Range
0.1254.035
Key Statistics
Prev. Close
3.62
Open
3.615
Day's Range
3.61-3.815
52 wk Range
0.125-4.035
Volume
600.11K
Average Volume (3m)
2.03M
1-Year Change
589.79%
Book Value / Share
0.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TOI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.000
Upside
+88.43%
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Oncology Institute Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Oncology Institute Inc Company Profile

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Oncology Institute Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue up 10.3% YoY to $104.4M; EPS at -$0.21, missing expectations
  • Stock surged 15.19% post-earnings despite EPS miss; company appears undervalued per InvestingPro analysis
  • Adjusted EBITDA and free cash flow improved YoY; full-year 2025 guidance reaffirmed
  • CEO targets sustained cash flow positivity and profitability in H2 2025; expects profitability in 2026
  • Risks include drug pricing regulations, profitability challenges, market saturation, and macroeconomic pressures
Last Updated: 14/05/2025, 22:48
Read Full Transcript

Compare TOI to Peers and Sector

Metrics to compare
TOI
Peers
Sector
Relationship
P/E Ratio
−6.5x−1.6x−0.5x
PEG Ratio
−0.450.010.00
Price/Book
67.8x1.6x2.6x
Price / LTM Sales
0.9x1.1x3.2x
Upside (Analyst Target)
91.3%45.0%42.0%
Fair Value Upside
Unlock23.8%6.6%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.000
(+88.43% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.21 / --
Revenue / Forecast
104.40M / --
EPS Revisions
Last 90 days

TOI Income Statement

People Also Watch

113.61
CRDO
+3.87%
1.865
ONDS
+2.47%
229.38
LEU
+2.37%
24.48
TSSI
+3.33%
6.1900
EOSE
+3.95%

FAQ

What Stock Exchange Does Oncology Institute Trade On?

Oncology Institute is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Oncology Institute?

The stock symbol for Oncology Institute is "TOI."

What Is the Oncology Institute Market Cap?

As of today, Oncology Institute market cap is 331.86M.

What Is Oncology Institute's Earnings Per Share (TTM)?

The Oncology Institute EPS (TTM) is -0.70.

When Is the Next Oncology Institute Earnings Date?

Oncology Institute will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is TOI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Oncology Institute Stock Split?

Oncology Institute has split 0 times.

How Many Employees Does Oncology Institute Have?

Oncology Institute has 825 employees.

What is the current trading status of Oncology Institute (TOI)?

As of 30 Jul 2025, Oncology Institute (TOI) is trading at a price of 3.72, with a previous close of 3.62. The stock has fluctuated within a day range of 3.61 to 3.82, while its 52-week range spans from 0.13 to 4.04.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.